• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外排作用对流感嗜血杆菌中泰利霉素和大环内酯类药物敏感性的影响。

Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae.

作者信息

Bogdanovich Tatiana, Bozdogan Bülent, Appelbaum Peter C

机构信息

Department of Pathology, Hershey Medical Center, P.O. Box 850, Hershey, Pennsylvania 17033, USA.

出版信息

Antimicrob Agents Chemother. 2006 Mar;50(3):893-8. doi: 10.1128/AAC.50.3.893-898.2006.

DOI:10.1128/AAC.50.3.893-898.2006
PMID:16495248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1426444/
Abstract

This study investigated the presence of telithromycin and azithromycin efflux in 58 clinical strains of Haemophilus influenzae with various susceptibilities to macrolides, azalides, and ketolides. Efflux pumps were studied by measuring accumulation of radioactive [3H]telithromycin and [N-methyl-3H]azithromycin in the presence and absence of carbonyl m-chlorophenylhydrazone (CCCP), a protonophore. In 17 strains for which the telithromycin MICs were 0.06 to 0.5 microg/ml (azithromycin MICs, < or = 0.06 to 0.125 microg/ml; clarithromycin MICs, < or = 0.06 to 2 microg/ml), telithromycin and azithromycin accumulations were high without CCCP and not affected by its addition, which indicates absence of efflux. In 22 strains for which the telithromycin MICs were 0.25 to 4 microg/ml (azithromycin MICs, 0.25 to 1 microg/ml; clarithromycin MICs, 1 to 8 microg/ml), initially low levels of telithromycin accumulation became higher after addition of CCCP, indicating a functioning efflux pump. Nineteen strains for which the telithromycin MICs were > or = 2 microg/ml had efflux as well as various mutations in ribosomal proteins L4, L22, and/or 23S rRNA (domains II and V). Of these 19 strains, the telithromycin MICs (> or = 8 microg/ml) for 17 of them were significantly raised (azithromycin, MICs 4 to >32 microg/ml; clarithromycin MICs, 8 to >32 microg/ml). From these results we conclude that telithromycin efflux with or without additional ribosomal alterations is present in all H. influenzae strains, except for those for which the telithromycin MICs were very low.

摘要

本研究调查了58株对大环内酯类、氮杂内酯类和酮内酯类具有不同敏感性的流感嗜血杆菌临床菌株中泰利霉素和阿奇霉素的外排情况。通过测量在存在和不存在羰基间氯苯腙(CCCP,一种质子载体)的情况下放射性[3H]泰利霉素和[N-甲基-3H]阿奇霉素的积累来研究外排泵。在17株泰利霉素MIC为0.06至0.5微克/毫升(阿奇霉素MIC,≤0.06至0.125微克/毫升;克拉霉素MIC,≤0.06至2微克/毫升)的菌株中,未添加CCCP时泰利霉素和阿奇霉素的积累量很高,且添加CCCP后不受影响,这表明不存在外排。在22株泰利霉素MIC为0.25至4微克/毫升(阿奇霉素MIC,0.25至1微克/毫升;克拉霉素MIC,1至8微克/毫升)的菌株中,添加CCCP后最初较低的泰利霉素积累水平升高,表明存在起作用的外排泵。19株泰利霉素MIC≥2微克/毫升的菌株存在外排以及核糖体蛋白L4、L22和/或23S rRNA(结构域II和V)的各种突变。在这19株菌株中,其中17株的泰利霉素MIC(≥8微克/毫升)显著升高(阿奇霉素MIC,4至>32微克/毫升;克拉霉素MIC,8至>32微克/毫升)。根据这些结果,我们得出结论,除了泰利霉素MIC非常低的菌株外,所有流感嗜血杆菌菌株均存在泰利霉素外排,无论是否有额外的核糖体改变。

相似文献

1
Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae.外排作用对流感嗜血杆菌中泰利霉素和大环内酯类药物敏感性的影响。
Antimicrob Agents Chemother. 2006 Mar;50(3):893-8. doi: 10.1128/AAC.50.3.893-898.2006.
2
Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.两种新型大环内酯类药物GW 773546和GW 708408与泰利霉素、红霉素、阿奇霉素及克拉霉素相比,对流感嗜血杆菌的抗菌活性。
Antimicrob Agents Chemother. 2004 Nov;48(11):4113-9. doi: 10.1128/AAC.48.11.4113-4119.2004.
3
Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates.外排机制和核糖体突变对流感嗜血杆菌临床分离株大环内酯类药物敏感性的影响。
Antimicrob Agents Chemother. 2003 Mar;47(3):1017-22. doi: 10.1128/AAC.47.3.1017-1022.2003.
4
Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.两种新型大环内酯类药物GW 773546和GW 708408与红霉素、阿奇霉素、克拉霉素、克林霉素和泰利霉素相比的抗肺炎球菌活性。
Antimicrob Agents Chemother. 2004 Nov;48(11):4103-12. doi: 10.1128/AAC.48.11.4103-4112.2004.
5
Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin.检测方法的差异对流感嗜血杆菌对氨苄西林、阿奇霉素、克拉霉素和泰利霉素敏感性的影响。
J Clin Microbiol. 2001 Jan;39(1):43-6. doi: 10.1128/JCM.39.1.43-46.2001.
6
In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations.泰利霉素在上皮衬液浓度下对流感嗜血杆菌的体外活性。
BMC Microbiol. 2008 Jan 29;8:23. doi: 10.1186/1471-2180-8-23.
7
Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides.与大环内酯类药物相比,泰利霉素对流感嗜血杆菌、卡他莫拉菌和链球菌的耐药性选择。
J Antimicrob Chemother. 2004 Aug;54(2):542-5. doi: 10.1093/jac/dkh339. Epub 2004 Jun 23.
8
Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli.CmeABC外排泵与空肠弯曲菌对大环内酯类抗生素耐药性的关系。
J Antimicrob Chemother. 2005 Nov;56(5):948-50. doi: 10.1093/jac/dki292. Epub 2005 Sep 12.
9
Kinetic bactericidal activity of telithromycin, azithromycin and clarithromycin against respiratory pathogens.泰利霉素、阿奇霉素和克拉霉素对呼吸道病原体的动态杀菌活性。
APMIS. 2005 Oct;113(10):655-63. doi: 10.1111/j.1600-0463.2005.apm_195.x.
10
Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.新型广谱头孢菌素头孢托罗对流感嗜血杆菌和卡他莫拉菌的活性。
Antimicrob Agents Chemother. 2006 Jun;50(6):2050-7. doi: 10.1128/AAC.00044-06.

引用本文的文献

1
Clinical Status of Efflux Resistance Mechanisms in Gram-Negative Bacteria.革兰氏阴性菌外排耐药机制的临床状况
Antibiotics (Basel). 2021 Sep 16;10(9):1117. doi: 10.3390/antibiotics10091117.
2
Staphylococcus aureus with an erm-mediated constitutive macrolide-lincosamide-streptogramin B resistance phenotype has reduced susceptibility to the new ketolide, solithromycin.具有 erm 介导的组成型大环内酯-林可酰胺-链阳性菌素 B 耐药表型的金黄色葡萄球菌对新型酮内酯类药物索利霉素的敏感性降低。
BMC Infect Dis. 2019 Feb 19;19(1):175. doi: 10.1186/s12879-019-3779-8.
3
The return of Pfeiffer's bacillus: Rising incidence of ampicillin resistance in Haemophilus influenzae.Pfeiffer 杆菌再现:流感嗜血杆菌氨苄西林耐药率上升。
Microb Genom. 2018 Sep;4(9). doi: 10.1099/mgen.0.000214. Epub 2018 Sep 12.
4
Azithromycin Pharmacodynamics against Persistent Haemophilus influenzae in Chronic Obstructive Pulmonary Disease.阿奇霉素对慢性阻塞性肺疾病中持续性流感嗜血杆菌的药效动力学
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.01995-17. Print 2018 Feb.
5
Risk Factors for Drug-Resistant Cap in Immunocompetent Patients.免疫功能正常患者耐碳青霉烯类肺炎克雷伯菌感染的危险因素
Curr Infect Dis Rep. 2017 Mar;19(3):11. doi: 10.1007/s11908-017-0565-x.
6
Effect of Fluoroquinolones and Macrolides on Eradication and Resistance of Haemophilus influenzae in Chronic Obstructive Pulmonary Disease.氟喹诺酮类和大环内酯类药物对慢性阻塞性肺疾病中流感嗜血杆菌根除及耐药性的影响
Antimicrob Agents Chemother. 2016 Jun 20;60(7):4151-8. doi: 10.1128/AAC.00301-16. Print 2016 Jul.
7
Chemistry and biology of macrolide antiparasitic agents.大环内酯类抗寄生虫药物的化学与生物学。
J Med Chem. 2011 Apr 28;54(8):2792-804. doi: 10.1021/jm101593u. Epub 2011 Mar 23.
8
Efflux-mediated drug resistance in bacteria: an update.细菌中由外排介导的耐药性:最新进展
Drugs. 2009 Aug 20;69(12):1555-623. doi: 10.2165/11317030-000000000-00000.
9
Recombineering reveals a diverse collection of ribosomal proteins L4 and L22 that confer resistance to macrolide antibiotics.重组工程揭示了多种赋予对大环内酯类抗生素抗性的核糖体蛋白L4和L22。
J Mol Biol. 2009 Feb 20;386(2):300-15. doi: 10.1016/j.jmb.2008.12.064. Epub 2009 Jan 3.
10
In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations.泰利霉素在上皮衬液浓度下对流感嗜血杆菌的体外活性。
BMC Microbiol. 2008 Jan 29;8:23. doi: 10.1186/1471-2180-8-23.

本文引用的文献

1
Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.两种新型大环内酯类药物GW 773546和GW 708408与泰利霉素、红霉素、阿奇霉素及克拉霉素相比,对流感嗜血杆菌的抗菌活性。
Antimicrob Agents Chemother. 2004 Nov;48(11):4113-9. doi: 10.1128/AAC.48.11.4113-4119.2004.
2
The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli.AcrAB-TolC泵与产气肠杆菌和大肠杆菌对大环内酯类药物的耐药性有关,但与泰利霉素的外排无关。
Antimicrob Agents Chemother. 2004 Sep;48(9):3621-4. doi: 10.1128/AAC.48.9.3621-3624.2004.
3
Inability of L22 ribosomal protein alteration to increase macrolide MICs in the absence of efflux mechanism in Haemophilus influenzae HMC-S.在无流感嗜血杆菌HMC-S外排机制的情况下,L22核糖体蛋白改变无法增加大环内酯类药物的最低抑菌浓度。
J Antimicrob Chemother. 2004 Aug;54(2):393-400. doi: 10.1093/jac/dkh364. Epub 2004 Jul 8.
4
Identification of the Haemophilus influenzae tolC gene by susceptibility profiles of insertionally inactivated efflux pump mutants.通过插入失活外排泵突变体的药敏谱鉴定流感嗜血杆菌tolC基因
Antimicrob Agents Chemother. 2004 Apr;48(4):1416-8. doi: 10.1128/AAC.48.4.1416-1418.2004.
5
Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.免疫功能正常的成年人社区获得性肺炎管理实践指南的更新
Clin Infect Dis. 2003 Dec 1;37(11):1405-33. doi: 10.1086/380488. Epub 2003 Nov 3.
6
Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates.外排机制和核糖体突变对流感嗜血杆菌临床分离株大环内酯类药物敏感性的影响。
Antimicrob Agents Chemother. 2003 Mar;47(3):1017-22. doi: 10.1128/AAC.47.3.1017-1022.2003.
7
Telithromycin: the first of the ketolides.泰利霉素:首个酮内酯类药物。
Ann Pharmacother. 2002 Mar;36(3):452-64. doi: 10.1345/aph.1A038.
8
Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications.对大环内酯类和林可酰胺类药物的耐药机制:耐药元件的性质及其临床意义。
Clin Infect Dis. 2002 Feb 15;34(4):482-92. doi: 10.1086/324626. Epub 2002 Jan 11.
9
Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters.利用药代动力学和药效学参数优化抗菌治疗
Clin Microbiol Infect. 2001 Nov;7(11):589-96. doi: 10.1046/j.1198-743x.2001.00295.x.
10
Novel macrolide-specific ABC-type efflux transporter in Escherichia coli.大肠杆菌中新型大环内酯特异性ABC型外排转运蛋白。
J Bacteriol. 2001 Oct;183(19):5639-44. doi: 10.1128/JB.183.19.5639-5644.2001.